Press release
Rising Incidence Of HER2-Positive Breast Cancer Drives Market Growth: A Significant Driver Propelling The Macugen Market In 2025
Macugen
What Is the Macugen Market Size and Projected Growth Rate?
In recent periods, the market size of Macugen has witnessed an XX% hike (HCAGR). It's predicted to rise from $XX million in 2024 to $XX million in 2025, displaying a compound annual growth rate (CAGR) of XX%. The significant development in the historical period can be traced back to factors such as a surge in the elderly population, heightened patient awareness, a rise in healTH*Care expenditure, an expansion in research and development pursuits, and growth in emerging markets.
The size of the Macugen market is anticipated to increase at a constant rate of XX% (FCAGR) over the coming years, reaching a value of $XX million by 2029. This expansion in the forecast period can be ascribed to higher rates of diagnosis and treatment, a growing prevalence of both wet AMD and AMD overall, escalating investments in health care facilities, and a heightened awareness of diabetic eye disorders. Notable trends predicted for the forecast period encompass a shift towards combination treatments, advancements in medication delivery systems, technology-driven innovations in ophthalmology, increased sophistication in diagnostic methodologies, and the development of better treatments for AMD.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20440
What Are the Major Segments in the Macugen Market?
The macugen market covered in this report is segmented -
1) By Indication: Wet AMD(Age-Related Macular Degeneration (AMD)); Diabetic Macular Edema
2) By Formulation: Intravitreal Injection; Extended-Release Formulations
3) By Distribution Channel: Hospitals And Clinics; Retail And Specialty Pharmacies
4) By End User: Adult Patients; Geriatric Patients
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20440&type=smp
What Are The Driving Macugen Market Evolution?
The escalating incidences of age-related macular degeneration (AMD), a progressive eye ailment affecting the macula - the main section of the retina responsible for clear and precision vision, are projected to stimulate the advancement of the macugen market. The growth in AMD cases is mainly due to an increasing global elderly population, longer lifespans, and lifestyle aspects including smoking, inadequate diet, and extended contact with ultraviolet (UV) light. Macugen is proven to be advantageous for AMD as it suppresses vascular endothelial growth factor (VEGF), curbs anomalous blood vessel expansion and seepage in the retina, aiding in vision preservation and slowing the pace of disease advancement. For example, in May 2023, the National Center for Biotechnology Information, a government agency of the US-based National Institutes of Health, featured an article predicting that around 288 million people will be afflicted by AMD by 2040. Consequently, the escalating occurrences of age-related macular degeneration (AMD) are fueling the expansion of the macugen market.
Which Firms Dominate The Macugen Market Segments?
Major companies operating in the macugen market are Bausch + Lomb Inc
What Are the Latest Developing Trends in the Macugen Market?
The prominent trend observed in the macugen market is the progression of gene therapy. This technique revolves around inserting genetic material into a patient's cells for disease treatment or prevention, specifically addressing age-related macular degeneration (AMD). For instance, Regenxbio, a biotechnology firm from the U.S., in 2023, introduced RGX-314, a gene therapy solution crafted to deliver a gene encoding for an anti-VEGF protein directly into the eye. This pioneering treatment is designed to offer long-term effects by reducing the necessity for regular injections. Uniqueness of RGX-314 can be observed in its potential for a single administration, substantially enhancing patient compliance, and its capability to address the root causes of AMD instead of only controlling symptoms. These forward strides position firms advantageously in the rapidly evolving ocular therapy landscape.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/macugen--global-market-report
Which Is The Largest Region In The Macugen Market?
North America was the largest region in the macugen market in 2024. The regions covered in the macugen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Macugen Market?
2. What is the CAGR expected in the Macugen Market?
3. What Are the Key Innovations Transforming the Macugen Industry?
4. Which Region Is Leading the Macugen Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Incidence Of HER2-Positive Breast Cancer Drives Market Growth: A Significant Driver Propelling The Macugen Market In 2025 here
News-ID: 4068385 • Views: …
More Releases from The Business Research Company
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector.
Projected Growth and Market Size of the Nano Antibodies Market
The nano antibodies market is anticipated…
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward.
Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody…
Top Players and Competitive Dynamics in the Menopause Supplement Market
The menopause supplement market is set for significant expansion in the coming years, driven by evolving healthcare demands and growing awareness of women's wellness. As more individuals seek tailored health solutions, the market is responding with innovative products and services designed to support women during menopause and beyond. Below, we explore the market size, influential players, and emerging trends shaping this industry's future.
Expected Growth Trajectory of the Menopause Supplement Market
The…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The market for liquid carbon dioxide storage tanks is set for strong expansion in the coming years, supported by rising sustainability priorities and steady technological advancements across multiple industries. A closer look at the market size, major players, evolving trends, and detailed segmentation provides a clear understanding of the current dynamics and future potential.
Projected Growth and Market Size of Liquid Carbon Dioxide Storage Tanks
The liquid carbon dioxide storage tanks market…
More Releases for Macugen
Emerging Macugen Market Driver 2025-2034: The Role Of AMD Prevalence In Driving …
How Is the Macugen Market Projected to Grow, and What Is Its Market Size?
In recent times, the market size of Macugen has seen an $XX (CAGR) rise. It's predicted to escalate from $XX million in 2024 to $XX million in 2025, displaying a compound annual growth rate (CAGR) of $XX%. Factors like the growth of the elderly population, an increase in patient awareness, escalated healthcare spending, a surge in…
Gene Therapies Market Report- Production Strategies and Challenges in the Manufa …
“Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” discusses all gene therapies, including not only those which involve genetic modification, but also RNAi, CAR-T cell and aptamer-based therapies.
Get a FREE PDF Sample Copy of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1344314
Currently Approved Gene Therapies in this Report-
Glybera (alipogene tiparvovec)
Kynamro (mipomersen)
Macugen (pegaptanib)
Vitravene…
Gene Therapies Market Report-Growth, Current Scenario and Future Aspect Analysis …
The research reports on Gene Therapies Market report gives detailed overview of factors that affect global business scope. Gene Therapies Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. Gene Therapies Market report contains emerging players analyze data including competitive situations, sales, revenue and market share of top manufacturers.
Get FREE…
Choroidal Neovascularization Market to Register Steady Expansion During 2017-202 …
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also…
Choroidal Neovascularization Market to Significant Growth Foreseen by 2017 - 202 …
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also…
Retinal Vein Occlusion Therapeutics Market Analysis by Key Growth Factors and Op …
Retinal vein occlusion (RVO) is one of the major cause of visual loss among the geriatric population. RVO is the second common cause of blindness after diabetic retinopathy. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). The BRVO occurs when the vein in the distal retinal system gets…
